SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
  
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
KOSKI CHRISTINE L

(Last) (First) (Middle)
1500 WEST UNIVERSITY PARKWAY

(Street)
SARASOTA FL 34232

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
ORAGENICS INC [ ORNI ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director X 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
06/29/2009
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
Form filed by One Reporting Person
X Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 06/29/2009 P 50,000,000 A $0.08 50,000,000 D(1)(2)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Warrants $0.1 06/29/2009 A 1,000,000 06/29/2009 06/28/2014 Common Stock 1,000,000 $0 1,000,000 D(1)(2)
Non-Employee Director Option (Right to Buy) $0.1 06/29/2009 A 100,000 06/29/2009 06/28/2019 Common Stock 100,000 $0 100,000 D(3)
Non-Employee Director Option (Right to Buy) $0.1 06/29/2009 A 100,000 06/29/2009 06/28/2019 Common Stock 100,000 $0 100,000 D(4)
1. Name and Address of Reporting Person*
KOSKI CHRISTINE L

(Last) (First) (Middle)
1500 WEST UNIVERSITY PARKWAY

(Street)
SARASOTA FL 34232

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
X Director X 10% Owner
Officer (give title below) Other (specify below)
1. Name and Address of Reporting Person*
KOSKI BEVERLY

(Last) (First) (Middle)
1500 WEST UNIVERSITY PARKWAY

(Street)
SARASOTA FL 34232

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
1. Name and Address of Reporting Person*
KOSKI FAMILY LP

(Last) (First) (Middle)
1500 WEST UNIVERSITY PARKWAY

(Street)
SARASOTA FL 34232

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
1. Name and Address of Reporting Person*
KOSKI ROBERT C

(Last) (First) (Middle)
1500 WEST UNIVERSITY PARKWAY

(Street)
SARASOTA FL 34232

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
X Director X 10% Owner
Officer (give title below) Other (specify below)
1. Name and Address of Reporting Person*
KOSKI THOMAS L

(Last) (First) (Middle)
1500 WEST UNIVERSITY PARKWAY

(Street)
SARASOTA FL 34232

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
Explanation of Responses:
1. Shares and warrants owned directly by Koski Family Limited Partnership. Shares and warrants owned indirectly by Beverly Koski, Christine L. Koski, Robert C. Koski and Thomas L. Koski, each of who is a general partner of the partnership or the controlling person of a corporate general partner of the partnership.
2. Shares and warrants acquired from the issuer in a private placement on June 29, 2009 at which time Christine L. Koski and Robert C. Koski were appointed directors.
3. Issuance of stock option to Christine L. Koski in connection with her appointment to the Board of Directors pursuant to the Amended and Restated 2002 Stock Option and Incentive Plan. The option vests on June 29, 2009 and has an exercise price of $.10 which was the closing price on the date of grant of June 29, 2009.
4. Issuance of stock option to Robert C. Koski in connection with his appointment to the Board of Directors pursuant to the Amended and Restated 2002 Stock Option and Incentive Plan. The option vests on June 29, 2009 and has an exercise price of $.10 which was the closing price on the date of grant of June 29, 2009.
/s/ Edward J. Richardson, as attorney-in-fact for Koski Family Limited Partnership, Christine L. Koski, Robert C. Koski, Beverly Koski and Thomas Koski 07/02/2009
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.